This is a new treatment for those who are ALK+. It is currently being evaluated by the Scottish Medicines Consortium. If you have any comments or experiences you would be willing to share can you let me know. Feedback from anywhere in the UK welcome, it would be used as part of the Patient and Clinician Experience Session which is designed to look at the impact of treatment alongside research data.
If you wish to post comments here or send me a private message, any feedback welcomed.